For well over a decade Shauna has been leading litigation teams in complex fraud cases in both state and federal courts. Shauna’s nationwide practice has focused on representing plaintiffs in various settings, including class action securities and consumer matters; antitrust; and cases involving patient harm. Shauna also has extensive experience representing whistleblowers in False Claims Act lawsuits, and tax and securities whistleblowers with claims under the IRS and SEC whistleblower programs. After obtaining her law degree, Shauna sought to represent plaintiffs because of her deep-seated notions of fairness and her desire to represent individuals who wanted to bring corporate fraud to light. She believes the key to success in complex litigation is using experience to lay bare various defense tactics that are designed to obscure the truth. Shauna’s temperament brings a sense of calmness to her litigation teams, even under the most demanding conditions. Using her legal skills, vision, work-ethic, and attention to detail, she has regularly generated multi-million-dollar settlements for her clients.
Prior to becoming an attorney, Shauna received a B.A. and an M.A. from Stanford University, where she was two-time captain of the University’s women’s nationally ranked soccer team. She received her J.D. from Villanova University.
Shauna is an avid volunteer and educator. She has served as an adjunct professor at Villanova University (2011-2013) and Widener Law School (2013-2018), teaching corporate deviance courses. Shauna currently serves as co-chair of Stanford University Alumni Undergraduate Admissions Volunteer Interview Program, and is the President of the Junior League of Philadelphia, Inc., an organization of approximately 800 women committed to promoting voluntarism, developing the potential of women, and improving the community through the effective action and leadership of trained volunteers.
- New Jersey
- U.S. District Court, Eastern District of Pennsylvania
- U.S. District Court, District of New Jersey
- U.S. Court of Appeals, Third Circuit
Pro Bono & Volunteer Experiences:
- Co-Chair of Stanford University Alumni Undergraduate Admissions Volunteer Interview Program (2012- present).
- Volunteer Attorney with HIAS; represented a client in removal hearings in Immigration Court: In the Matter of Isabelita Hidalgo Rodriguez, A 087-760-543 (April 2013).
- Legal Team Leader of Philadelphia Bar Association ACE Program Legal Team (Team of Attorneys Teaching Advanced Civics Education to High School Freshman and Elementary School children in the Philadelphia School District).
- Volunteer Attorney with Veterans Consortium Pro Bono Program representing veterans denied benefits in Veterans Appellate Court (2009 – present). Successfully represented veterans in their appeal before the U.S. Court of Appeals for Veterans Claims (CAVC): Gerald G. Woodley v. Eric K. Shinseki, App. No. 10-0312 and Linda Abercrombie v. Eric K. Shinseki, Vet. App. No. 11-3021.
- Volunteer Attorney Advocate with Support Center for Child Advocates (2016 – 2018).
- Member of the American Bar Association Professional Responsibility Continuing Education Committee (2017-2018).
- Board Member of the Pregnancy After Loss Support Group, nonprofit (2016 – 2018).
- Member of the Steering Committee of the City Year Philadelphia’s Annual Women’s Leadership Luncheon (2014-2017).
- In addition to her legal pro bono endeavors, Shauna volunteers her time to other non-profits. She is the President of the Junior League of Philadelphia in 2019-2020, where she has previously served as the Director of Development and Board Member of the Junior League of Philadelphia (May 2012-May 2014), the Chief Operating Officer of the League (May 2014 – present), and the Secretary of the Board (May 2016-May 2017), and will be the Parliamentarian (May 2017-May 2018).
- Shauna was an Adjunct Professor at Widener Law School (2013-2018) and Villanova University (2010-2103), teaching courses on White Collar Crime and Corporate Deviance.
- United States ex rel. Outerbridge v. UTC Laboratories LLC et al, Case No. 15-1445, (E.D. La.): Represented one of the whistleblowers in a case in which Renaissance RX, a genetic testing lab, and its executives were found to have improperly paid or offered kickbacks to outside salespeople, including Shauna’s client, Kevin Outerbridge. The whistleblowers disclosed improper activity, including sending out salespeople to persuade members of the public to submit to medically unnecessary genetic testing. The Federal Court assessed the company and executives more than $42 million in fines.
- The “Clean Diesel cases. Part of the litigation team working on the multi-billion-dollar lawsuits brought against BMW, General Motors, Ford Motors, and Mercedes for allegedly disguising the actual emission levels of their diesel engine cars. The settlement figure in these cases make them “the largest auto-related consumer class-action settlement in U.S. history,” lawyers told The Star of Toronto.
- In re: Pharmaceutical Industry Average Wholesale Price Litigation: part of a litigation team that worked extensively with the Department of Justice and State Attornies General across the nation representing whistleblowers in a series of False Claims Act cases against drug companies for fraudulent Medicaid and Medicare drug pricing which has led to more than $3 billion in recoveries. Federal and State Qui Tam Litigation (In re: Pharmaceutical Industry Average Wholesale Price Litigation), Lead Case Number 1:01cv12257 (D. Mass.).
- In United States et al. ex rel. Silver v. PharMerica et al., 1:11-cv-01326, Shauna drafted the appellate briefing for and argued the appeal before the federal Third Circuit. The case alleged that institutional pharmacy PharMerica Corporation violated the False Claims Act and defrauded the government by providing kickbacks to nursing homes. At the oral argument, Chief Judge Michael A. Chagares stated: “I want to thank and congratulate counsel for excellent argument and excellent briefing in this case.” The Third Circuit panel of judges reversed and remanded the case. In so doing, the panel issued a precedential opinion, making favorable law on an important public disclosure issue.
- S. ex rel. Gale v. Omnicare, Inc., Civil Action Number 1:10-cv-0127 (N.D. Ohio) and United States et al ex rel. Marc Silver v. Omnicare, Inc. et al., Civil Action Number 11-01326 (D.NJ): Member of trial team of False Claims Act case which settled for $120 million. These two cases alleged that defendant Omnicare defrauded the government by providing kickbacks to nursing homes.
- United States ex rel. John Doe, v. Recovery Home Care, Mark Conklin, and Glen Castillo, 8:12-cv-2495 (M.D. Fla): Lead attorney in a case alleging the defendants violated the False Claims Act by provided remuneration to physicians to induce patient referrals and reward physicians for prior referrals in violation of the Anti- Kickback Statute and the Stark Law. Cases settled for $5 million (collectively).
- Mazur v. Concord Camera et al., Case No. 04-61159 (S.D. Fla. 2004): Assisted in litigation brought in the Southern District of Florida against defendant Concord Camera Corp. and several of its officers seeking damages on behalf of the class for violations of Section 10(b) of the Securities and Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, and against the officers of the Company for violations of Section 20(a) of the Securities and Exchange Act of 1934 that resulted in a $2 million settlement.
- In re: Adams Golf Securities Litigation, Civ. Action No. 99-371 (D. Del. 1999): Assisted in litigation brought in the District of Delaware against Adams Golf and its top officers, directors, and underwriters alleging violations of sections 11, 12(a)(2) and 15 of the Securities Act of 1933 in connection with Adams Golf’s IPO in 1998. Specifically, Plaintiffs allege that the offering materials misrepresented and failed to disclose the material risk posed by gray marketing. Case settled for $16.5 million.
- In re: American Business Financial Services, Inc. Noteholders Litigation,05-232 (E.D. Pa.): Assisted in federal securities class action brought against top officers and directors of the now-bankrupt American Business Financial Services alleging a violation of Section 11 of the Securities Act of 1933 Act. Plaintiffs charged that defendants made false statements in the Registration Statements and Prospectuses that American Business filed with the SEC during 2001-2003.
- United States ex rel. Janet Burke v. Norman A. Brooks, M.D. Inc. et al., Civ 14-6735 (C.D. Cal.): Lead attorney in False Claims Act case against Dr. Norman A. Brooks, M.D.—a dermatologist and surgeon—settled for $2,681,400. Case alleged that Defendants routinely, and as a pattern and practice, falsely diagnosed the great majority of its patients as having the third stage of skin cancer, which would yield the maximum cost-effective Medicare reimbursement.
- United States ex rel. Sharp v. Americare Ambulance, 8:13-cv-01171-VMC-AEP (M.D. Fla.): Lead attorney in False Claims Act case that settled for $5.5 Million in January 2018 for allegedly billing Medicare for medically unnecessary ambulance transports.
- United States ex rel. Doe v. Covidien et al., Case No. 8:15-cv-01796-AG-JCG: Lead Attorney in False Claims Act case alleging defendant engaged in a kickback scheme settled for $13 million in December 2018.
- United States ex rel. Hospitality Management, Inc. v. Pinnacle, Case No. 12CV000095-F (D. Wy.): Lead attorney in False Claims Act case alleging Pinnacle Bank defrauded the government buy making false certifications in Small Business Association loan documents. Case settled for $3 million.
*Prior results do not guarantee or predict a similar outcome in any future matter.
Publications & Presentations
Publications & Presentations
Shauna is a nationally recognized speaker and has published numerous articles:
Published an article, “Adding Whistleblower/Qui Tam Cases to Your Practice Areas” in the American Bar Association GPSolo eReport of December 9, 2019.
Will lead an ABA webinar, “Adding Whistleblower/Qui Tam Cases to Your Solo or Small Firm Practice,” on February 26, 2020, at 1:00 PM Eastern time. One can register for the event here: https://www.americanbar.org/events-cle/mtg/web/392963320/
Will record a Continuing Legal Education class with the National Academy of Continuing Legal Education, “The Whistleblower Laws: Spot A Claim, Avoid Traps for the Unwary, and Earn a Bounty for Your Clients.” The website for the Academy is here: https://www.nacle.com/
Will speak at the Third Annual Healthcare Compliance Symposium with Delaware Law School in Wilmington, DE, on April 23rd, 2020. More information and registration are here. https://www.eventbrite.com/e/healthcare-compliance-symposium-2020-tickets-81343158577.
Will speak on “Fraud, Waste, and Abuse in Clinical Research” at Avera Research Integrity Conference: Creating and Promoting a Culture of Research Integrity. The conference is in Sioux Falls, S.D., on April 17, 2020.
Participated in a panel discussion at Taxpayers Against Fraud (premier national annual qui tam conference), conference in September 2019 in Washington, D.C. on “Blowing the Whistle in the Digital Age.”
Moderated a panel for the ABA Professional Responsibility Committee’s CLE entitled, “Ethically Interviewing and Preparing Witnesses for Deposition and Trial” (February 2018).
Spoke at “Predictive Coding – A Love Story,” at the Taxpayers Against Fraud Annual Conference, Washington D.C., October 2018.
Presented at the American Bar Association’s 12th National Institute on the Civil False Claims Act and Qui Tam Enforcement, Washington, D.C. from June 13–15, 2018.
Spoke on “Updates in False Claims Act Litigation,” at the SOCRA Annual Conference in New Orleans September 28-30, 2018.
Presented at “False Claims Act and Healthcare,” Healthcare Compliance Symposium at Delaware Law School on April 12, 2018.
Spoke at “Fraud, Waste and Abuse in Clinical Research,” Association of Clinical Research Professionals (ACRP) Global Conference, April 2015 in Salt Lake City.
Spoke at “Fraud, Waste and Abuse in Clinical Research,” SOCRA, Society of Clinical Research Associates 24th Annual Conference, September 2015 in Denver (+4000 attendees).
Gave a six-part 60-minute Webinar with Solo Practice University entitled “Introduction to Whistleblower Acts.” (www.solopracticeuniversity.com).
Spoke at Taxpayers Against Fraud November 2015, Washington, D.C.
Presented at “Whistleblower Acts,” American Bar Association Section of Litigation Annual Conference in Chicago (April 2013).
Spoke at the Association of Clinical Research Professionals (ACRP) Global Conference, “Fraud Enforcement in Clinical Research under the False Claims Act,” April 26, 2014 in San Antonio.
Moderated a panel entitled “Basics of Litigating Under The False Claims Act,” at the National Employment Lawyer Association’s 2013 Fall Seminar, called “Shining The Light On Whistleblower & Retaliation Claims,” in Washington, DC on October 18, 2013.
Spoke at “Fraud, Waste and Abuse in Clinical Research,” SOCRA, Society of Clinical Research Associates 24th Annual Conference in Denver, September 2015 (+4000 attendees).
Delivered a webinar with First Healthcare Compliance, “False Claims Act and Healthcare.”
Taught as a Visiting Professor on Business Ethics for Comcast’s Financial Management Program.
Presented at “An Introduction to Whistleblower/Qui Tam Claims”, American Bar Association 101/201 Practice Series.
Delivered two webinars with First Healthcare Compliance. The first in March 2014 titled “The False Claims Act (Whistleblower Actions) And Healthcare. The second in October 2017 titled “False Claims Act Liability and Whistleblower Laws.”
Wrote “Violations of Good Laboratory Practice Regulations Can Potentially Lead to False Claims Act Liability,” The Monitor, Association of Clinical Research Professionals (“ACRP”).
Published an article with the National Employment Lawyer Association, titled “Release of Claims and the False Claims Act: An Employee’s Ability To Pursue Qui-Tam Claims Against Its Former Employer After Signing a Release,” In October 2011.
Published an article, “The False Claims Act (“Whistleblower Act”) Effectively Fights Fraud, Waste, and Abuse in Clinical Research, Studies and Trials,” in the May 2019 Life Science Leader.